A New Chapter for MicMac.

Effective May 1, 2026, Micromacinazione (MicMac) has officially joined Microsize's global platform, following the completion of the acquisition from Lonza by Microsize and Schedio Group. The Monteggio site continues to operate under the same name, with the same team and full continuity of GMP micronization services — for both clinical and commercial supply.

This is more than a change of ownership. It is the foundation of an integrated, cross-continental particle engineering network, combining MicMac's European expertise with Microsize's US capabilities and Schedio's engineering know-how. One integrated standard. Two continents. A single trusted partner for pharmaceutical customers worldwide.